Posts Tagged ‘patent expiration’

New patent expiration for Novo Nordisk drug LEVEMIR

Annual Drug Patent Expirations for LEVEMIR Levemir is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There are sixteen…
The post New patent expiration for Novo Nordisk drug LEVEMIR appeared first o…


New patent expiration for Novo Nordisk drug RYZODEG 70/30

Annual Drug Patent Expirations for RYZODEG+70%2F30 Ryzodeg 70/30 is a drug marketed by Novo Nordisk Inc and is included in one NDA. There are eleven patents protecting this drug. This…
The post New patent expiration for Novo Nordisk drug RYZODEG 70/30 …


New patent expiration for Baxter Hlthcare drug EXTRANEAL

Annual Drug Patent Expirations for EXTRANEAL Extraneal is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Baxter Hlthcare drug EXTRANEAL appeare…


New patent expiration for Novo Nordisk drug LEVEMIR FLEXPEN

Annual Drug Patent Expirations for LEVEMIR+FLEXPEN Levemir Flexpen is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Novo Nordisk drug LEVEMIR FLEXPEN …


New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT

Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are twenty-five…
The post New patent expiration for Boehringer Ingelhei…


New patent expiration for Glaxosmithkline drug VENTOLIN HFA

Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from eleven suppliers. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug VEN…


New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT

Annual Drug Patent Expirations for SPIRIVA+RESPIMAT Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are nineteen…
The post New patent expiration for Boehringer Ingelheim d…


New patent expiration for Abbvie drug BIAXIN XL

Annual Drug Patent Expirations for BIAXIN+XL Biaxin Xl is a drug marketed by Abbvie and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Abbvie drug BIAXIN XL appeared first on DrugPa…


Drug Patent Expirations for the Week of June 11, 2017

ARRANON (nelarabine) Novartis pharms corp Patent: 5,424,295 Expiration: Jun 13, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post Drug …


Patent Expirations Will Stabilize the Pharmaceutical Industry

“Patent Expirations Will Stabilize the Pharmaceutical Industry.” I must believe it, because I’m quoted in the St. Louis Observer as having said it! The reporter did a good job of capturing what I meant, quoting me as saying “the industry will be more diverse, with a more stable, though smaller, revenue base spread among many […]


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog